ZBH · 8-K · 20260805PR333761

Net Income and EPS Performance

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 51 · Surprise 38

Second-quarter diluted EPS was $1.03, up 33.8% from $0.77 in the prior-year quarter. Second-quarter net earnings attributable to Zimmer Biomet were $198.3 million versus $152.8 million, while adjusted net earnings were $399.6 million and adjusted diluted EPS was $2.07, unchanged year over year. First-half diluted EPS increased to $2.25 from $1.68, and first-half net earnings attributable to Zimmer Biomet increased to $436.5 million from $334.9 million.

Key facts

• Second quarter adjusted net earnings (As Adjusted): $399.6 million source
• Second quarter diluted earnings per share: $1.03, an increase of 33.8% source
• Second quarter net earnings (GAAP): $198.3 million source
• Three months net earnings before noncontrolling interest (Net Earnings): $199.6 million and net earnings attributable to noncontrolling interest: $1.3 million source
• Weighted average common shares outstanding diluted for the three months ended June 30, 2026: 192.8 and basic: 192.2 source
• Weighted average common shares outstanding diluted for the six months ended June 30, 2026: 194.3 and basic: 193.6 source
• Second quarter adjusted diluted earnings per share: $2.07, consistent with the prior year period source